New directions in GABAergic pharmacology of anxiety and depression

A. V. Kaluev*, D. J. Nutt

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

New prospects in the use of drugs affecting central GABAergic system for the treatment of anxiety and depressive states are critically assessed. Both clinical (human) and experimental (animal) data on the mutual influence of various GABA-receptor modulators as well as the interaction of GABAergic system with neurohumoral mechanisms of stress are considered. Based on this analysis, new strategies in the GABAergic pharmacotherapy of anxiety and depression spectrum disorders are outlined.

Original languageEnglish
Pages (from-to)3-7
Number of pages5
JournalEksperimental'naya i Klinicheskaya Farmakologiya
Volume67
Issue number6
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'New directions in GABAergic pharmacology of anxiety and depression'. Together they form a unique fingerprint.

Cite this